Arkolith/Insider Trading/FBIO/Form 4

Rosenwald Lindsay A MD

PRESIDENT, CEO & CHAIRMAN, Director, 10% OwnerFortress Biotech, Inc. (FBIO) · full profile →Form 4 · filed Dec 5, 2022
Net Buying
Open-Market Buys
$68K
Open-Market Sells
$0
Net Open-Market Flow
$68K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 1, 2022Buy(P)100K$0.68$68K11.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-124392) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML